KCVSX
Price
$18.19
Change
-$0.50 (-2.68%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

KCVSX vs RMFCX

Header iconKCVSX vs RMFCX Comparison
Open Charts KCVSX vs RMFCXBanner chart's image
Knights of Columbus Large Cap Value S
Price$18.19
Change-$0.50 (-2.68%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
KCVSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
KCVSX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KCVSX is a StrongSell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. KCVSX (240M). RMFCX pays higher dividends than KCVSX: RMFCX (1.69) vs KCVSX (0.99). KCVSX was incepted earlier than RMFCX: KCVSX (9 years) vs RMFCX (23 years). KCVSX is a more actively managed with annual turnover of: 37.00 vs. RMFCX (25.00). KCVSX has a lower initial minimum investment than RMFCX: KCVSX (0) vs RMFCX (250). KCVSX annual gain was more profitable for investors over the last year : 22.63 vs. RMFCX (12.63). KCVSX return over 5 years is better than : 47.56 vs. RMFCX (40.39).
KCVSXRMFCXKCVSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD21.12711.423185%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets240M98.7B0%
Annual Yield % from dividends0.991.6959%
Returns for 1 year22.6312.63179%
Returns for 3 years20.4214.16144%
Returns for 5 years47.5640.39118%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc